Stock Price
6.52
Daily Change
0.21 3.33%
Monthly
15.19%
Yearly
-16.52%
Q1 Forecast
5.91

Inogen reported $197.18M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.13B 1.3B Dec/2025
Accuray USD 61.87M 19.3M Sep/2025
AngioDynamics USD 185.87M 898K Feb/2025
Artivion USD 438.69M 18.79M Sep/2025
AtriCure USD 491.94M 15.43M Dec/2025
Baxter International USD 6.13B 1.11B Dec/2025
Becton, Dickinson and Co. USD 25.28B 108M Dec/2025
Boston Scientific USD 24.23B 1.58B Dec/2025
Chart Industries USD 3.23B 28.2M Dec/2025
Cooper Companies USD 8.24B 113.7M Sep/2025
Dexcom USD 2.75B 19.9M Dec/2025
Edwards Lifesciences USD 10.2B 340.3M Sep/2025
Globus Medical USD 4.57B 174.42M Dec/2025
Inogen USD 197.18M 2.32M Sep/2025
Insulet USD 1.52B 131.1M Dec/2025
Masimo USD 721.2M 88.8M Dec/2025
Medtronic USD 48.86B 964M Sep/2025
Orthofix International USD 442.49M 15.86M Sep/2025
Philips EUR 10.58B 204M Sep/2025
ResMed USD 6.32B 199.61M Dec/2025
Steris USD 7.15B 145.4M Dec/2025
Stryker USD 21.78B 594M Sep/2025
Tandem Diabetes Care USD 155.17M 22.2M Dec/2025
Teleflex USD 3.12B 697.09M Dec/2025
X T L Biopharmaceuticals USD -47K 5.48M Jun/2025
Zimmer Biomet Holdings USD 12.7B 68.3M Dec/2025